Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed2
Recruiting1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT05204329Early Phase 1Completed
Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
CorneaCorneal DefectCorneal Epithelium Defect+1 more
PrincipalinvestigatorStart date: 2024-01-24
NCT05705024Phase 2Recruiting
Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells
Corneal Ulcer
PrincipalinvestigatorStart date: 2023-09-29
NCT04626583Phase 1Completed
Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells
CorneaCorneal DefectMesenchymal Stromal Cells+1 more
PrincipalinvestigatorStart date: 2021-03-05

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Charlotte E Joslin, OD, PhD

University of Illinois at Chicago

Very Similar
3 trials

Shared therapeutic areas:

CorneaCorneal DefectMesenchymal Stromal Cells+3 more

Worked with same sponsors:

National Eye Institute (NEI)National Institutes of Health (NIH)+2 more
Collaborated on 3 trials
Similarity Score72%

Elmer Y Tu, MD

University of Illinois at Chicago

Moderately Similar
1 trials

Shared therapeutic areas:

CorneaCorneal DefectCorneal Epithelium Defect+1 more

Worked with same sponsors:

National Eye Institute (NEI)National Institutes of Health (NIH)+1 more
Collaborated on 1 trial
Similarity Score44%

Graciela Trujillo, MD

HOSPITAL DOCTOR NEGRIN

Related
1 trials

Shared therapeutic areas:

Corneal Ulcer
Similarity Score5%

Yves Donazzolo, MD

Eurofins Optimed

Related
8 trials

Shared therapeutic areas:

Safety
Similarity Score5%

Carlos Lopez Gutierrez, MD

HOSPITAL GALDAKAO

Related
1 trials

Shared therapeutic areas:

Corneal Ulcer
Similarity Score5%

Sergio Schalka

Grupo Medcin

Related
5 trials

Shared therapeutic areas:

Safety
Similarity Score5%

Eric Sicard, M.D.

Algorithme Pharma Inc

Related
10 trials

Shared therapeutic areas:

Safety
Similarity Score5%

Brendan Smyth

AstraZeneca

Related
6 trials

Shared therapeutic areas:

Safety
Similarity Score5%

Annetine C Gelijns, PhD

Icahn School of Medicine at Mount Sinai

Related
4 trials

Shared therapeutic areas:

Mesenchymal Stromal Cells
Similarity Score5%

Sharon L Hillier, PhD

University of Pittsburgh

Related
11 trials

Shared therapeutic areas:

Safety

Worked with same sponsors:

National Institutes of Health (NIH)
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05204329Early Phase 1PrincipalInvestigator

Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease

CorneaCorneal DefectCorneal Epithelium Defect+1 more
Completed
NCT05705024Phase 2PrincipalInvestigator

Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells

Corneal Ulcer
Recruiting
NCT04626583Phase 1PrincipalInvestigator

Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells

CorneaCorneal DefectMesenchymal Stromal Cells+1 more
Completed

All 3 trials loaded